SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : eDrugstores: Drugstore.com, PlanetRx and Soma

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: H James Morris who wrote (204)9/6/1999 11:39:00 AM
From: H James Morris   of 254
 
TomD, What do you think of this Physician?
>>Upshot: Online drugstore PlanetRx hopes to go public soon. Among the
liabilities that shareholders will buy into is an expensive deal to
acquire domain names.

The Deal: Physician and photojournalist Matthew Naythons scarfed up
domain names and peddled them to PlanetRx (where he's VP of editorial
and publishing) for a rosy prognosis: 690,000 shares and a split of
any revenue from the sites, up to $500,000.

The Dish: The domains could prove valuable. But PlanetRx is mum on the
sale and other curiosities, like why eToys gets a right of first
refusal if PlanetRx sells the names fertility.com and infertility.com
before 2004.

The Take: No details yet on PlanetRx's IPO. But the company's sale of
stock to funders at $8.76 per share puts Naythons' stake at $6 million
- before the usual IPO run-up. Not bad for an ex-journalist who bought
up a handful of Web domain names.<<
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext